Wayfair: Q3 Earnings Snapshot - WTOP News
Wayfair: Q3 Earnings Snapshot Wayfair Inc. reported a loss of $99 million in its third quarter, with a loss of 76 cents per share. Earnings, adjusted for debt and stock option expen…
TCT 2025: STORM-PE Trial Demonstrates Safety and Efficacy of Mechanical Thrombectomy in Intermediate-High-Risk Pulmonary Embolism
TCT 2025: STORM-PE Trial Demonstrates Safety and Efficacy of Mechanical Thrombectomy in Intermediate-High-Risk Pulmonary Embolism The STOR…
Pivoting from Exploration to Production: Mining's Moment
Pivoting from Exploration to Production: Mining's Moment Over the past year, gold, silver and other precious metals have staged a consiste…
UK businesses more likely to rely on brokers for risk management than global peers - Insurance Age
UK Businesses Rely on Brokers for Risk Management UK businesses are more likely to rely on brokers to identify major risks (78.3%) compare…
In Review: Big-Ass Sword by Andreas Butzbach
In Review: Big-Ass Sword by Andreas Butzbach Luke Williams reviews Andreas Butzbach's first graphic novel published in English. In…
E.ON plugs in with Nokia for network upgrade
E.ON Partners with Nokia for Network Upgrade E.ON Group, an energy company, has signed a five-year deal with Nokia to modernize its missio…
Redefining Urban Living Through Harmony Between City and Nature
Redefining Urban Living Through Harmony Between City and Nature The concept of "Tbilisi Acres" represents a modern urban settlement that c…
Giving States Waivers From Accountability Is a Dangerous Step Backward for Kids
Giving States Waivers From Accountability Is a Dangerous Step Backward for Kids By loosening testing and reporting requirements, the Educa…
Cygnet Energy Enters into Agreement to Acquire Kiwetinohk Energy Corp.
Cygnet Energy Enters into Agreement to Acquire Kiwetinohk Energy Corp. Cygnet Energy Ltd., a private exploration and production company, h…
Novartis to Acquire Avidity Biosciences for US$12 Billion in Rare-Disease Push
Novartis to Acquire Avidity Biosciences for US$12 Billion Novartis will buy Avidity Biosciences for US$12 billion, gaining its RNA-based t…
Remedy Robotics partners with Mission Thrombectomy to expand robotic thrombectomy access
Remedy Robotics Partners with Mission Thrombectomy Remedy Robotics has entered a strategic partnership with Mission Thrombectomy, a leadin…